Healthcare provider profile · identity verified

Stefanie Anne Jimenez, ARNP

Nurse Practitioner · MARSHALLTOWN, IA · NPI 1285399758

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	377	112
Levothyroxine Sodium	Levothyroxine Sodium	361	92
Omeprazole	Omeprazole	236	75
Lisinopril	Lisinopril	211	62
Gabapentin	Gabapentin	198	44
Metoprolol Succinate	Metoprolol Succinate	174	47
Losartan Potassium	Losartan Potassium	171	59
Metformin Hcl	Metformin Hcl	168	46
Simvastatin	Simvastatin	161	59
Amlodipine Besylate	Amlodipine Besylate	160	55
Hydrochlorothiazide	Hydrochlorothiazide	131	36
Tramadol Hcl	Tramadol Hcl	111	46
Pantoprazole Sodium	Pantoprazole Sodium	101	26
Sertraline Hcl	Sertraline Hcl	95	30
Jardiance	Empagliflozin	88	16
Ozempic	Semaglutide	88	16
Potassium Chloride	Potassium Chloride	82	24
Eliquis	Apixaban	80	14
Albuterol Sulfate Hfa	Albuterol Sulfate	79	34
Furosemide	Furosemide	78	27
Prednisone	Prednisone	71	55
Tamsulosin Hcl	Tamsulosin Hcl	66	25
Escitalopram Oxalate	Escitalopram Oxalate	64	15
Allopurinol	Allopurinol	62	15
Montelukast Sodium	Montelukast Sodium	59	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	21
Rosuvastatin Calcium	Rosuvastatin Calcium	57	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	30
Trazodone Hcl	Trazodone Hcl	54	28
Metformin Hcl Er	Metformin Hcl	51	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Pregabalin	Pregabalin	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	16
Famotidine	Famotidine	48	12
Lorazepam	Lorazepam	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	16
Diclofenac Sodium	Diclofenac Sodium	42	17
Symbicort	Budesonide/Formoterol Fumarate	42	suppressed
Baclofen	Baclofen	40	11
Mirtazapine	Mirtazapine	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Clonazepam	Clonazepam	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	11
Oxybutynin Chloride Er	Oxybutynin Chloride	35	11
Hydroxyzine Hcl	Hydroxyzine Hcl	34	14
Metoprolol Tartrate	Metoprolol Tartrate	34	14
Meloxicam	Meloxicam	33	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Cephalexin	Cephalexin	31	24
Fluticasone Propionate	Fluticasone Propionate	31	16
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Alprazolam	Alprazolam	30	13
Glimepiride	Glimepiride	29	suppressed
Nystatin	Nystatin	29	11
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Fentanyl	Fentanyl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	26
Warfarin Sodium	Warfarin Sodium	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	15
Ezetimibe	Ezetimibe	27	suppressed
Glipizide	Glipizide	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Topiramate	Topiramate	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	20
Verapamil Er	Verapamil Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Fluconazole	Fluconazole	20	16
Januvia	Sitagliptin Phosphate	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Azithromycin	Azithromycin	18	16
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Carvedilol	Carvedilol	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Atenolol	Atenolol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Naproxen	Naproxen	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Tri-Sprintec	Norgestimate-Ethinyl Estradiol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Finasteride	Finasteride	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Zafemy	Norelgestromin/Ethin.Estradiol	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error